US BioTek Laboratories Merges With NutriPATH Pathology
March 3, 2026
US BioTek Laboratories, a Seattle-based functional laboratory, has completed a strategic merger with Australian functional pathology provider NutriPATH Pathology based in Melbourne. The combined organization expands functional pathology and diagnostic testing capabilities and extends international access for healthcare providers, while NutriPATH continues operating under its established brand in Australia.
- Buyers
- US BioTek Laboratories
- Targets
- NutriPATH Pathology, NutriPATH
- Industry
- Healthcare Services
- Location
- Victoria, Australia
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.